Literature DB >> 12053271

Central nervous system infections in individuals with HIV-1 infection.

Arunima Mamidi1, Joseph A DeSimone, Roger J Pomerantz.   

Abstract

Opportunistic infections of the central nervous system (CNS) are common complications of advanced immunodeficiency in individuals with human immunodeficiency virus type 1 (HIV-1) infection. Neurological disease is the first manifestation of acquired immunodeficiency syndrome (AIDS) in 10% to 20% of symptomatic HIV-1 infection. Prompt diagnosis and treatment of such disorders is critical. Also, in the era of highly active antiretroviral therapy (HAART), these disease states have changed in presentation and epidemiology. Therefore, we review the epidemiology, pathogenesis, clinical features, diagnosis, and management of five common central nervous system disorders in individuals with HIV-1 infection: toxoplasma encephalitis, primary central nervous system lymphoma, cryptococcal meningitis, cytomegalovirus encephalitis, and progressive multifocal leukoencephalopathy.

Entities:  

Mesh:

Year:  2002        PMID: 12053271     DOI: 10.1080/13550280290049723

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  92 in total

1.  Remission of AIDS-associated progressive multifocal leukoencephalopathy after cidofovir therapy.

Authors:  A M Brambilla; A Castagna; R Novati; P Cinque; M R Terreni; M C Moioli; A Lazzarin
Journal:  J Neurol       Date:  1999-08       Impact factor: 4.849

2.  Long-term remission of AIDS-related primary central nervous system lymphoma associated with highly active antiretroviral therapy.

Authors:  J P McGowan; S Shah
Journal:  AIDS       Date:  1998-05-28       Impact factor: 4.177

Review 3.  Primary central nervous system lymphoma in patients with AIDS.

Authors:  A Ruiz; M J Post; C Bundschu; W I Ganz; M Georgiou
Journal:  Neuroimaging Clin N Am       Date:  1997-05       Impact factor: 2.264

4.  JC virus-specific cytotoxic T lymphocytes in individuals with progressive multifocal leukoencephalopathy.

Authors:  I J Koralnik; R A Du Pasquier; N L Letvin
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

5.  Minimally invasive diagnosis of acquired immunodeficiency syndrome-related primary central nervous system lymphoma.

Authors:  A Cingolani; A De Luca; L M Larocca; A Ammassari; M Scerrati; A Antinori; L Ortona
Journal:  J Natl Cancer Inst       Date:  1998-03-04       Impact factor: 13.506

6.  A comparison of itraconazole versus fluconazole as maintenance therapy for AIDS-associated cryptococcal meningitis. National Institute of Allergy and Infectious Diseases Mycoses Study Group.

Authors:  M S Saag; G A Cloud; J R Graybill; J D Sobel; C U Tuazon; P C Johnson; W J Fessel; B L Moskovitz; B Wiesinger; D Cosmatos; L Riser; C Thomas; R Hafner; W E Dismukes
Journal:  Clin Infect Dis       Date:  1999-02       Impact factor: 9.079

7.  PCR detection of Toxoplasma gondii DNA in CSF for the differential diagnosis of AIDS-related focal brain lesions.

Authors:  A Cingolani; A De Luca; A Ammassari; R Murri; A Linzalone; R Grillo; A Antinori
Journal:  J Med Microbiol       Date:  1996-12       Impact factor: 2.472

8.  Ganciclovir treatment of cytomegalovirus ventriculitis in a patient infected with human immunodeficiency virus.

Authors:  T A Price; R A Digioia; G L Simon
Journal:  Clin Infect Dis       Date:  1992-10       Impact factor: 9.079

9.  Level of cytomegalovirus (CMV) DNA in cerebrospinal fluid of subjects with AIDS and CMV infection of the central nervous system.

Authors:  J R Arribas; D B Clifford; C J Fichtenbaum; D L Commins; W G Powderly; G A Storch
Journal:  J Infect Dis       Date:  1995-08       Impact factor: 5.226

10.  Prolonged survival and partial recovery in AIDS-associated progressive multifocal leukoencephalopathy.

Authors:  J R Berger; L Mucke
Journal:  Neurology       Date:  1988-07       Impact factor: 9.910

View more
  43 in total

1.  Evaluation and treatment of chronic meningitis.

Authors:  Kelly J Baldwin; Joseph R Zunt
Journal:  Neurohospitalist       Date:  2014-10

2.  High-throughput growth assay for Toxoplasma gondii using yellow fluorescent protein.

Authors:  Marc-Jan Gubbels; Catherine Li; Boris Striepen
Journal:  Antimicrob Agents Chemother       Date:  2003-01       Impact factor: 5.191

3.  Iopamidol-induced meningoencephalopathy in an HIV-seropositive patient.

Authors:  Jeffrey S Stroup; Johnny R Stephens; Damon L Baker
Journal:  Proc (Bayl Univ Med Cent)       Date:  2007-01

Review 4.  Immunotherapeutic relief from persistent infections and amyloid disorders.

Authors:  Dorian B McGavern
Journal:  Neurology       Date:  2006-01-24       Impact factor: 9.910

5.  [Neurological complications of HIV infection].

Authors:  G Arendt; T Nolting
Journal:  Nervenarzt       Date:  2008-12       Impact factor: 1.214

Review 6.  IL-23 in infections, inflammation, autoimmunity and cancer: possible role in HIV-1 and AIDS.

Authors:  Govardhana Rao Yannam; Tanuja Gutti; Larisa Y Poluektova
Journal:  J Neuroimmune Pharmacol       Date:  2011-09-24       Impact factor: 4.147

7.  Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.

Authors:  George K Siberry; Mark J Abzug; Sharon Nachman; Michael T Brady; Kenneth L Dominguez; Edward Handelsman; Lynne M Mofenson; Steve Nesheim
Journal:  Pediatr Infect Dis J       Date:  2013-11       Impact factor: 2.129

Review 8.  A meta-analysis of HIV and heart rate variability in the era of antiretroviral therapy.

Authors:  Roger C McIntosh
Journal:  Clin Auton Res       Date:  2016-07-09       Impact factor: 4.435

9.  The effect of highly active antiretroviral therapy on outcome of central nervous system herpesviruses infection in Cuban human immunodeficiency virus-infected individuals.

Authors:  Pedro Ariel Martínez; René Díaz; Daniel González; Lisset Oropesa; Ruby González; Lissette Pérez; Jenniffer Viera; Vivian Kourí
Journal:  J Neurovirol       Date:  2007-10       Impact factor: 2.643

10.  Multiple-ring enhancing lesions in an immunocompetent adult.

Authors:  Amit Agrawal; Arvind Bhake; Vm Sangole; Brij R Singh
Journal:  J Glob Infect Dis       Date:  2010-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.